Clinical trial
Autologous Purified Bone-Marrow-Derived Stem Cell Therapy for Motor Neuron Disease
NCT03067857 is registered in ClinicalTrials.gov with Stem Cells Arabia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Autologous Purified Bone-Marrow-Derived Stem Cell Therapy for Motor Neuron Disease
- Lead sponsor
- Stem Cells Arabia
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- September 30, 2016
- Completion date
- August 31, 2019
- Enrollment
- 40 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
amyotrophic lateral sclerosis, motor neuron disease, primary lateral sclerosis, progressive bulbar palsies, progressive muscular atrophy